CL2011001017A1 - Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster. - Google Patents

Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster.

Info

Publication number
CL2011001017A1
CL2011001017A1 CL2011001017A CL2011001017A CL2011001017A1 CL 2011001017 A1 CL2011001017 A1 CL 2011001017A1 CL 2011001017 A CL2011001017 A CL 2011001017A CL 2011001017 A CL2011001017 A CL 2011001017A CL 2011001017 A1 CL2011001017 A1 CL 2011001017A1
Authority
CL
Chile
Prior art keywords
irritation
carrier
pharmaceutical composition
reinforcing agent
pain associated
Prior art date
Application number
CL2011001017A
Other languages
English (en)
Inventor
Edward T Kisak
Smith R Dominic Galer Bradley S Newsam John M Buyuktimkin Nadir King
Servet Singh Jagat Buyuktimkin
Original Assignee
Nuvo Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41508318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011001017(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nuvo Res Inc filed Critical Nuvo Res Inc
Publication of CL2011001017A1 publication Critical patent/CL2011001017A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición farmacéutica acuosa que no provoca ardor ni irritación, que comprende un ingrediente anestésico de acción tópica, un alcanol inferior, un agente reforzador de la penetración molecular y un portador; su uso para aliviar el dolor asociado con herpes zóster.
CL2011001017A 2008-11-06 2011-05-05 Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster. CL2011001017A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11212308P 2008-11-06 2008-11-06

Publications (1)

Publication Number Publication Date
CL2011001017A1 true CL2011001017A1 (es) 2011-09-30

Family

ID=41508318

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011001017A CL2011001017A1 (es) 2008-11-06 2011-05-05 Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster.

Country Status (6)

Country Link
US (1) US20110288123A1 (es)
EP (1) EP2349337A1 (es)
BR (1) BRPI0921604A2 (es)
CA (1) CA2742603A1 (es)
CL (1) CL2011001017A1 (es)
WO (1) WO2010054093A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007033083A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
EP2324838A1 (en) 2005-09-12 2011-05-25 Abela Pharmaceuticals, Inc. Compositions Comprising Dimethyl Sulfoxide (DMSO)
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
CA2805749A1 (en) 2009-08-26 2011-03-10 Nuvo Research Inc. Pharmaceutical formulations and methods of use
MX353712B (es) 2009-10-30 2018-01-24 Abela Pharmaceuticals Inc Formulaciones de sulfoxido de dimetilo (dmso) y metilsulfonilmetano (msm) para tratar osteoartritis.
US8846725B2 (en) * 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
EA030797B1 (ru) 2012-12-21 2018-09-28 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Система трансдермальной доставки гормонов (варианты) и способы ее применения
GB201305622D0 (en) * 2013-03-27 2013-05-15 Sas Ltd Composition
US20150141515A1 (en) * 2013-11-20 2015-05-21 Firstline Meds, Inc. Compositions and methods for delivery of nsaid and anesthetic
US10039830B2 (en) * 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
US11951082B2 (en) 2022-08-22 2024-04-09 Ford Therapeutics, Llc Composition of chlorhexidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617282A1 (de) * 1965-11-30 1975-02-06 Astra Pharma Prod Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
JP3115625B2 (ja) * 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
US20030027833A1 (en) * 2001-05-07 2003-02-06 Cleary Gary W. Compositions and delivery systems for administration of a local anesthetic agent
WO2008088756A1 (en) * 2007-01-12 2008-07-24 Bridge Pharma, Inc. Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus

Also Published As

Publication number Publication date
CA2742603A1 (en) 2010-05-14
EP2349337A1 (en) 2011-08-03
US20110288123A1 (en) 2011-11-24
WO2010054093A1 (en) 2010-05-14
BRPI0921604A2 (pt) 2015-12-29

Similar Documents

Publication Publication Date Title
CL2011001017A1 (es) Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster.
BR112021022497A2 (pt) Composto, composição farmacêutica, uso da composição farmacêutica, e, métodos para prevenir ou tratar obesidade, diabetes, inflamação e disfunção erétil
MX2011011514A (es) Formulaciones de canabidiol y metodos para utilizarlas.
CO6470850A2 (es) Composición antimicrobiana humectante
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
BR112012010083B8 (pt) Composição farmacêutica tópica de liberação sustentada e uso relacionado
AR062622A1 (es) Formulaciones topicas para administracion local que contienen indoxacarb
CR8428A (es) Agente endoparasiticidas para la administracion topica
BRPI0921063B8 (pt) composto, e, composição agonística para receptor de melanocortina
BRPI0510842A (pt) composição e seu uso
CL2011002315A1 (es) Compuestos derivados de pirimidindiona fusionados con pirrol, moduladores de receptores trpa1; composicion farmaceutica; y uso para tratar el dolor cronico, dolor reumatoide artritico o dolor osteoartritico.
CL2008000188A1 (es) Agente para suprimir la reaccion de rechazo cronica que comprende como ingrediente activo un inhibidor de il-6; y uso del inhibidor de il-6.
AR054581A1 (es) Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion
BR112014016661A8 (pt) formulação de liberação prolongada para reduzir a frequência de urinação e método de uso da mesma
BR112014016550A8 (pt) formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
PE20081881A1 (es) Agentes terapeuticos para canceres resistentes a agentes quimioterapicos que incluyen como ingrediente activo un anticuerpo que reconoce hla de clase i y sus usos
CL2009000388A1 (es) Compuestos derivados de biciclos nitrogenados; proceso de preparacion; composicion farmaceutica; y su uso para tratar el dolor cronico que surge por inflamacion o neuropatia.
CL2009000660A1 (es) Uso de un antagonista del receptor 2 activado con proteasa (par2) para tratar, inhibir o aliviar el dolor.
CL2011001026A1 (es) Uso de pimobedan para preparar un medicamento util en el tratamiento de cardiomiopatia hipertrofica en un gato.
BRPI0912112B8 (pt) composição farmacêutica compreendendo composto tendo atividade antagonística em receptor de adenosina a2a útil em suprimir tolerância analgésica
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.
CL2011000268A1 (es) Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio.
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
ECSP13012524A (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia